The Effects of Lisdexamfetamine Dimesylate on Driving Behaviors in Young Adults With ADHD Assessed With the Manchester Driving Behavior Questionnaire

Journal of Adolescent Health, 05/08/2012

Lisdexamfetamine dimesylate (LDX) treatment was associated with significant improvements in self–reported driving behaviors that were independent of improvement in symptoms of ADHD. These results suggest that LDX may reduce behaviors associated with driving risks in young adults with ADHD.

Print Article Summary Cat 2 CME Report